We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

161 hedge funds and large institutions have $373M invested in Spectrum Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 70 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

443% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 7

218% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 22

26% more capital invested

Capital invested by funds: $296M → $373M (+$77.1M)

23% more funds holding

Funds holding: 131161 (+30)

20% less call options, than puts

Call options by funds: $646K | Put options by funds: $810K

Holders
161
Holders Change
+30
Holders Change %
+22.9%
% of All Funds
4.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
38
Increased
70
Reduced
22
Closed
7
Calls
$646K
Puts
$810K
Net Calls
-$164K
Net Calls Change
+$204K
Name Holding Trade Value Shares
Change
Change in
Stake
PP
101
PDT Partners
New York
$181K +$195K +27,600 New
EGA
102
Eagle Global Advisors
Texas
$179K
T. Rowe Price Associates
103
T. Rowe Price Associates
Maryland
$179K
AG
104
Aperio Group
California
$178K +$6.63K +939 +4%
LSERS
105
Louisiana State Employees Retirement System
Louisiana
$177K +$5.65K +800 +3%
MCM
106
Matarin Capital Management
New York
$176K +$189K +26,748 New
CSS
107
Cubist Systematic Strategies
Connecticut
$174K +$187K +26,525 New
QSS
108
Quantitative Systematic Strategies
Florida
$164K +$7.34K +1,039 +4%
NIT
109
NumerixS Investment Technologies
British Columbia, Canada
$163K +$16.3K +2,300 +10%
CCIA
110
Campbell & Co Investment Adviser
Maryland
$154K +$166K +23,450 New
Jane Street
111
Jane Street
New York
$141K -$106K -14,931 -41%
BCM
112
Bayesian Capital Management
New York
$134K +$144K +20,385 New
BNP Paribas Financial Markets
113
BNP Paribas Financial Markets
France
$126K +$74.4K +10,527 +123%
HIMCH
114
Hartford Investment Management Co (HIMCO)
Connecticut
$118K
AIM
115
Acrospire Investment Management
Illinois
$117K +$110K +15,564 +707%
CAM
116
Capstone Asset Management
Texas
$114K +$71 +10 +0.1%
SKK
117
Shepherd Kaplan Krochuk
Massachusetts
$114K +$123K +17,370 New
DIA
118
Denver Investment Advisors
Colorado
$110K -$24.9K -3,519 -17%
PA
119
Profund Advisors
Maryland
$108K +$5.77K +817 +5%
PAM
120
Paradigm Asset Management
New York
$101K +$108K +15,300 New
MERSOM
121
Municipal Employees' Retirement System of Michigan
Michigan
$90K +$5.94K +840 +7%
TRSOTSOK
122
Teachers Retirement System of the State of Kentucky
Kentucky
$89K
Squarepoint
123
Squarepoint
New York
$88K +$95K +13,447 New
Legal & General Group
124
Legal & General Group
United Kingdom
$85K
MSA
125
Mason Street Advisors
Wisconsin
$78K +$9.71K +1,374 +13%

SPPI Hedge Fund Activity: Q2 2016 in Review

161 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2016, worth a combined $373M — up 26% from $296M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new SPPI positions and 7 closed out — a net gain of 31 holders — while 70 added to existing stakes and 22 trimmed.

The largest buyer was Macquarie Group, adding an estimated $14.2M. The largest seller was Krensavage Asset Management, exiting entirely with an estimated $6.95M sold.

  • 161 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2016, up from 131 in Q1 2016.
  • Funds reported $373M of Spectrum Pharmaceuticals Inc stock for Q2 2016, up 26% quarter-over-quarter.
  • 38 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2016 and 7 closed out, a net change of +31 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2016 was Macquarie Group, an estimated $14.2M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2016 was Krensavage Asset Management, an estimated $6.95M sold.

Based on aggregated 13F filings for Q2 2016.